Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 3 Sarcoma 1 Recurrence 1 Neoplasm Metastasis 1 Meningeal Neoplasms 1 Inhibition, Psychological 1 Hereditary Sensory and Autonomic Neuropathies 1 Glioma 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

pembrolizumab 244 Carboplatin 213 Pemetrexed 179 Cisplatin 133 Paclitaxel 115 Nivolumab 102 Docetaxel 88 osimertinib 84 durvalumab 79 Specimen Handling 56 atezolizumab 55 Gemcitabine 53 Drug Therapy 53 Magnetic Resonance Spectroscopy 50 Radiosurgery 49 Radiotherapy 48 Ipilimumab 41 130-nm albumin-bound paclitaxel 39 cemiplimab 38 Bevacizumab 35 tislelizumab 31 Cetuximab 30 amivantamab 23 Taxes 22 Blood Specimen Collection 21 Platinum Compounds 20 Immunotherapy 18 Immune Checkpoint Inhibitors 18 Radiation 17 Erlotinib Hydrochloride 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × AZD1390 × 1 year × Clear all

NCT04550104 2025-12-19

CONCORDE

University of Leeds

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡